Abstract
An outbreak of digoxin intoxication brought about by an unannounced change affecting bioavailability by a manufacturer is reported. Public health implications are discussed.
Original language | English |
---|---|
Pages (from-to) | 643-646 |
Number of pages | 4 |
Journal | Clinical Pharmacology and Therapeutics |
Volume | 21 |
Issue number | 6 |
DOIs | |
State | Published - 1 Jan 1977 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)